Tandem Diabetes Care Files Registration Statement for Initial Public Offering

Tandem Diabetes Care Files Registration Statement for Initial Public Offering

PR Newswire

SAN DIEGO, Oct. 7, 2013

SAN DIEGO, Oct. 7, 2013 /PRNewswire/ --Tandem Diabetes Care®, Inc. ("Tandem")
a medical device company and manufacturer of the t:slim® Insulin Pump, today
announced that it has filed a registration statement on Form S-1 with the
Securities and Exchange Commission for a proposed initial public offering of
its common stock. The number of shares to be offered and the price range for
the offering have not yet been determined. Tandem plans to list its common
stock on the NASDAQ Global Market under the ticker symbol "TNDM."

BofA Merrill Lynch and Piper Jaffray will serve as joint book-running managers
for the offering. The offering will be made only by means of a prospectus.
When available, a copy of the preliminary prospectus may be obtained from:
BofA Merrill Lynch, 222 Broadway, New York, NY 10038 Attention: Prospectus
Department, by email at dg.Prospectus_Requests@baml.com; Piper Jaffray & Co.,
Attention: Equity Capital Markets, 800 Nicollet Mall, J12S03, Minneapolis, MN
55402, via telephone at 800-747-3924 or by email at prospectus@pjc.com.

A registration statement relating to the securities has been filed with the
Securities and Exchange Commission, but has not yet become effective. The
securities may not be sold nor may offers to buy be accepted prior to the time
the registration statement becomes effective. This news release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction in which
such an offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of such state or jurisdiction.

About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a medical device company with an innovative,
user-centric and integrated approach to the design, development and
commercialization of products for people with insulin-dependent diabetes. The
Company manufactures and sells the t:slim Insulin Pump, the slimmest and
smallest durable insulin pump currently on the market, and the first and only
with a high resolution, color touch screen. Tandem is based in San Diego,

SOURCE Tandem Diabetes Care, Inc.

Website: http://tandemdiabetes.com
Contact: Media, Steve Sabicer, 714-907-6264, ssabicer@thesabicergroup.com;
Investors, Susan Morrison, 858-366-6900 x7005, smorrison@tandemdiabetes.com
Press spacebar to pause and continue. Press esc to stop.